VEGF Inhibitor Shows its Mettle in Macular Edema, AMD

The VEGF inhibitor fusion protein improved visual acuity in macular edema secondary to central retinal vein occlusion, and was comparable to ranibizumab in age-related macular degeneration (AMD).
Medscape Medical News

Full Story →